iPath Pure Beta Sugar ETN
SGAR
SGAR was delisted on the 11th of April, 2018.
2 hedge funds and large institutions have $49K invested in iPath Pure Beta Sugar ETN in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
8% less capital invested
Capital invested by funds: $53K → $49K (-$4K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
NewSquare Capital
Newtown Square,
Pennsylvania
|
+$3.33K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$20.4K |
SGAR Hedge Fund Activity: Q2 2016 in Review
2 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta Sugar ETN (SGAR) for Q2 2016, worth a combined $49K — down 7.5% from $53K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new SGAR positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was NewSquare Capital, opening a new position worth an estimated $3.33K. The largest seller was UBS Group, cutting an estimated $20.4K.
- 2 institutional investors held iPath Pure Beta Sugar ETN (SGAR) as of Q2 2016, up from 1 in Q1 2016.
- Funds reported $49K of iPath Pure Beta Sugar ETN stock for Q2 2016, down 7.5% quarter-over-quarter.
- 1 fund opened new iPath Pure Beta Sugar ETN positions in Q2 2016 and 0 closed out, a net change of +1 holder.
- The largest iPath Pure Beta Sugar ETN buyer in Q2 2016 was NewSquare Capital, an estimated $3.33K added.
- The largest iPath Pure Beta Sugar ETN seller in Q2 2016 was UBS Group, an estimated $20.4K sold.
Based on aggregated 13F filings for Q2 2016.